Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 1 | BMC Immunology

Fig. 1

From: CD100 modulates cytotoxicity of CD8+ T cells in patients with acute myocardial infarction

Fig. 1

Comparison of soluble CD100 (sCD100) and matrix metalloproteinase-2 (MMP-2) level in the plasma among control group (n = 20), stable angina pectoris (SAP) group (n = 22), unstable angina pectoris (UAP) group (n = 20), and acute myocardial infarction (AMI) group (n = 23). Plasma sCD100 and MMP-2 was measured by ELISA. a Plasma sCD100 level was increased in AMI group than in control, SAP, and UAP group. b Plasma MMP-2 level was increased in AMI group than in control, SAP, and UAP group. Individual level for each subject was shown. The horizon lines indicated means, while the error bars indicated standard deviations. One-way ANOVA and SNK-q test was used for statistical analysis

Back to article page